Israeli-founded biotech exits for $11.9 billion

US giant Gilead has just bought Kite (a biotech founded by Israel’s Arie Belldegrun) for $11.9 billion.  Kite’s CAR-T technology was developed by Weizmann Institute’s Professor Zelig Eshhar. A patient’s own immune system T-cells are genetically engineered to attack tumors.

This entry was posted in Economy & Business. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *